OPTIMIZE-2: Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery (clinicaltrials.gov) - Nov 13, 2023 - P3 | N=160 | Not yet recruiting | Sponsor: Oculis
New P3 trial • Surgery • Cataract • Inflammation • Ocular Inflammation • Ophthalmology • Pain
|